Ventilator Associated Bacterial Pneumonia (VABP) (DBCOND0149717)

Identifiers

Synonyms
Ventilator Associated Bacterial Pneumonia / Pneumonia, Ventilator-Associated / Pneumonia, Ventilator Associated / Ventilator-associated Bacterial Pneumonia / Ventilator Associated Pneumonia ( VAP) / Pneumonia Ventilator Associated / Ventilator-Associated Pneumonia / Ventilator Associated Pneumonia / Ventilator Associated Pneumonia (VAP) / Ventilator-Associated Pneumonia (VAP) / VAP - Ventilator Associated Pneumonia / VABP / Ventilator-acquired pneumonia (disorder) / Unspecified bacterial pneumonia / Pneumonia, Bacterial / Bacterial pneumonia (disorder) / Pneumonia bacterial / Bacterial pneumonia, unspecified / Pneumonia bacterial NOS / Pneumonia, unspecified organism / Lung inflammation / Pneumonia / Pneumonia (disorder) / Pneumonia NOS / Pulmonitis

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Avibactam
A non-β-lactam β-lactamase inhibitor used in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and hospital or ventilator-acquired pneumonia.
Cefiderocol
A cephalosporin antibiotic used in complicated urinary tract infections.
Ceftobiprole medocaril
A broad spectrum 5th-generation cephalosporin antibacterial indicated for certain kinds of pneumonia, bacteremia, and skin and skin structure infections, including those caused by MRSA.
Ceftolozane
A cephalosporin antibiotic used to treat complicated intra-abdominal infections in combination with metronidazole, complicated urinary tract infections, and hospital-acquired pneumonia.
Tazobactam
A beta lactamase inhibitor administered with antibiotics such as piperacillin and ceftolozane to prevent their degradation, resulting in increased efficacy.
Telavancin
An antibacterial agent used in the treatment of complicated skin and skin structure infections and types of hospital-acquired bacterial pneumonia.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04215991
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participantstreatment2recruiting
NCT02288234
Telavancin Observational Use Registry (TOUR)Not AvailableNot Availablecompleted
NCT04264533
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumoniatreatment2terminated
NCT02542553
Bilateral Bronchoalveolar Lavage in Ventilator-associated PneumoniaNo drug interventionsdiagnosticNot Availablecompleted
NCT04839653
Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant BacteriapreventionNot Availableunknown_status
NCT06370598
Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated PneumoniaNo drug interventionstreatment1 / 2not_yet_recruiting
NCT03290105
Microbial and Pharmacological Assessment of ChlorhexidineNo drug interventionsNot AvailableNot Availablecompleted
NCT01110109
Removing Fluid Above Breathing Tubes in the Operating RoomNo drug interventionsNot AvailableNot Availablecompleted
NCT03816956
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301treatment3completed
NCT00572559
Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureustreatment4completed
NCT02413242
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICUNo drug interventionsNot AvailableNot Availablecompleted
NCT02950519
Endotracheal Tube Cuff Pressures in Ventilated PatientsNo drug interventionstreatmentNot Availablecompleted
NCT03401463
Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training SeminarNo drug interventionspreventionNot Availablecompleted
NCT02683122
The DIPOD Study (Diagnosis Improvement of Pneumonia by Organ Dysfunction)No drug interventionsNot AvailableNot Availablecompleted
NCT04269525
Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumoniaprevention2unknown_status
NCT01765530
Efficacy Study of a Novel Device to Clean the Endotracheal TubeNo drug interventionspreventionNot Availablecompleted
NCT02940626
Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.No drug interventionsprevention2terminated
NCT02689531
CTTI Risk Factors for HABP/VABP StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00529776
Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation TherapyNo drug interventionspreventionNot Availablecompleted
NCT00491660
Effect of Gravity on Tracheal Colonization During Mechanical Ventilation in InfantsNo drug interventionssupportive_careNot Availablecompleted
NCT03506191
Pneumonia Due to Stenotrophomonas Maltophilia in ICUsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01577862
Colistin and Rifampicin for MDR-Acinetobactertreatment3completed
NCT01123681
Intubation and Extubation Over 48 Hours Mechanical VentilationNo drug interventionsNot AvailableNot Availableunknown_status
NCT03105414
INCIPAVE Study: Incidence of Ventilator Acquired Pneumonia in ChildrenNo drug interventionsNot AvailableNot Availableunknown_status
NCT00986102
PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Regiontreatment4completed
NCT02756351
A Efficacy and Safety Study of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial ColonizationNo drug interventionspreventionNot Availablecompleted
NCT00521677
Comparison Between Two Methods of Oral Care on the Incidence of VAPNo drug interventionstreatmentNot Availablecompleted
NCT04381247
Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in NorwayNo drug interventionsNot AvailableNot Availablerecruiting
NCT04208945
Nebulized Colistin for Gram Negative VAP Prevention.preventionNot Availableunknown_status
NCT02326207
Weekly Versus no Routine Ventilator Circuit Changes in NICUNo drug interventionshealth_services_researchNot Availableterminated
NCT00876252
Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patientstreatment2completed
NCT02806141
Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonatestreatment3terminated
NCT00515034
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumoniatreatment2completed
NCT05214716
FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care UnitsNo drug interventionsdiagnosticNot Availableterminated
NCT05843786
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patientstreatment3recruiting
NCT05117125
Biomarkers for Ventilator-associated PneumoniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01640925
Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care UnitpreventionNot Availablecompleted
NCT02574130
Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative BacteriatreatmentNot Availablecompleted
NCT00965848
A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infectionstreatment4completed
NCT03711331
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired PneumoniaNo drug interventionstreatmentNot Availablerecruiting
NCT05405491
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical VentilationNo drug interventionstreatmentNot Availablerecruiting
NCT04346589
Convalescent Antibodies Infusion in Critically Ill COVID 19 PatientstreatmentNot Availableterminated
NCT03527992
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and PleuropneumoniaNo drug interventionstreatmentNot Availablerecruiting
NCT04215692
Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT01875692
Can we Better Understand the Development of VAP and Eventually Predict and Prevent it?No drug interventionsNot AvailableNot Availablecompleted
NCT03149640
Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumoniaprevention3completed
NCT04566172
Preoperative Optimization to Improve Functional StatusNo drug interventionspreventionNot Availablewithdrawn
NCT01356472
Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumoniatreatment4unknown_status
NCT04755972
Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2No drug interventionspreventionNot Availablecompleted
NCT04313946
Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-RaysNo drug interventionsNot AvailableNot Availableunknown_status
NCT01902446
Prehospital Ventilator-Associated Pneumonia Prevention TrialNot AvailableNot Availablecompleted
NCT02478710
Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumoniatreatment4terminated
NCT06039995
The Efficacy of Adjuvant Oral Care in Prevention of Ventilator Associated Pneumonia.No drug interventionspreventionNot Availablenot_yet_recruiting
NCT00610623
Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumoniaprevention2terminated
NCT02753608
Early Detection of Ventilator-associated Pneumonia (VAP)No drug interventionsdiagnosticNot Availablecompleted
NCT02683603
Effect of Aerosolised Colistin in Ventilator Associated Pneumoniatreatment4completed
NCT06467864
Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response: A Multi-center Prospective StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01110421
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumoniatreatment3terminated
NCT01559753
Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatmenttreatment4completed
NCT00542321
Pilot Study of Lateral Rotation Interventions for Efficacy and Safety in ICU CareNo drug interventionstreatmentNot Availablecompleted
NCT00447109
Time Interval for Changing Closed System Suction Catheters, Effect on Ventilator Associated PneumoniaNo drug interventionstreatmentNot Availablecompleted
NCT03583333
Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)treatment3completed
NCT06087536
A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii ComplexNo drug interventionstreatment2recruiting
NCT01865266
The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated PneumoniaNo drug interventionstreatment2 / 3unknown_status
NCT01292031
Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)treatment3completed
NCT03894046
Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complextreatment3completed
NCT02168946
Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adultstreatment3completed
NCT04107363
Oropharyngeal Aspiration to Reduce Ventilator-Related PneumoniaNo drug interventionspreventionNot Availablecompleted
NCT02420366
Study of Cases of Serious Infections Due to Carbapenem-Resistant EnterobacteriaceaeNo drug interventionsNot AvailableNot Availablecompleted
NCT05905055
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacteralestreatment3recruiting
NCT03006679
A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumoniatreatment3withdrawn
NCT04620941
Use of Reticulocyte Ratio and Neutrophil / Lymphocyte Ratio in the Diagnosis of Ventilator-associated PneumoniaNo drug interventionsNot AvailableNot Availablesuspended
NCT02652247
Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma PatientsNo drug interventionsdiagnosticNot Availableterminated
NCT04926493
Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Patients at Increased Risk for the Development of Ventilator-associated Pneumonia in the Intensive Care UnitNo drug interventionsNot AvailableNot Availableunknown_status
NCT02714595
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogenstreatment3completed
NCT02440828
Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumoniatreatment4completed
NCT01853982
Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumoniatreatment3terminated
NCT04029675
High Dose of Vitamin C on Mechanically Ventilated Septic Patients in Intensive Care UnitNo drug interventionsotherNot Availablecompleted
NCT05792501
Pulmonary Infections and Barotrauma Associated With MV IN PICUNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03032380
Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogenstreatment3completed
NCT01808092
A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumoniatreatment3completed
NCT01782755
Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trialprevention2completed
NCT02186951
Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complicationstreatment3completed
NCT02536547
Diagnostic Value of Pulmonary Ultrasound in the Diagnosis of Ventilator-associated PneumoniaeNo drug interventionsNot AvailableNot Availablecompleted
NCT00842478
Effectiveness of Dental Brushing for Preventing Ventilator-Associated PneumoniaNo drug interventionsprevention2 / 3unknown_status
NCT03581370
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumoniatreatment3unknown_status
NCT01314742
Study of Biotene OralBalance Gel for Oral Care in Critically-Ill Mechanically Ventilated Neonatesprevention0completed
NCT06118242
The Effect of Solutions Used in Oral Care on Preventing Ventilator-Associated Pneumonia.No drug interventionspreventionNot Availablenot_yet_recruiting
NCT00364299
Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff PressureNo drug interventionspreventionNot Availablecompleted
NCT06066736
Risks Factors and Outcome of Recurrences in Patients With Ventilator-Associated Pneumonias (REVAP)No drug interventionsNot AvailableNot Availablerecruiting
NCT01105819
Chlorhexidine vs Lactobacillus Plantarum for Oral Care in Intubated ICU PatientsNo drug interventionspreventionNot Availablecompleted
NCT01550419
Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Strokeprevention0unknown_status
NCT05450796
Prognosis and Virulence Determination of Capsule and Endotoxin During Klebsiella Spp. Ventilator-associated PneumoniasNo drug interventionsNot AvailableNot Availablerecruiting
NCT05877625
Study on Dynamic Environmental Exposome of ICU and the Establishment of Microbial Transmission Model Between Environment and HostNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01972425
Biomarker-based Exclusion of VAP for Improved Antibiotic StewardshipNo drug interventionspreventionNot Availablecompleted
NCT02897466
Impact of Direct Antimicrobial Susceptibility Testing on Respiratory Sample of Intensive Care Patient With Suspected VAPNo drug interventionsotherNot Availableunknown_status
NCT05589727
Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in BrazilNo drug interventionsNot AvailableNot Availablerecruiting
NCT02838160
Effectiveness of Different Educational Strategies on the KAP, Psychological and Clinical OutcomesNo drug interventionspreventionNot Availablecompleted
NCT00319644
Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated PneumoniaNo drug interventionsdiagnosticNot Availablecompleted
NCT05918172
Comparison of the Frequency of Ventilator-Associated Pneumonia in Intubated Patients Followed Up With Automatic Cuff Pressure Controller and Manual Cuff Pressure Controller in Pediatric Intensive CareNo drug interventionsNot AvailableNot Availablerecruiting
NCT02704923
Atropine for Preventing Ventilator-Associated Pneumoniaprevention2completed
NCT02244723
Diagnostic Value of Lung Ultrasound for Ventilator-Associated PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT02583308
Impact of the Subglottic Secretions Drainage on the Tracheal Secretions ColonisationNo drug interventionspreventionNot Availablecompleted
NCT00543608
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumoniatreatment2terminated
NCT03348579
Hospital-acquired Pneumonia in Intensive Care UnitNo drug interventionsNot AvailableNot Availablecompleted
NCT02779933
Epidemiology of Risk Factors for Hospital-acquired Pneumonia (HAP) in Intensive Care Unit (ICU) PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01406951
Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02973347
Impact of Intermittent and Continuous Enteral Feeding on Ventilator-associated Pneumonia in Pediatric ICUsNo drug interventionssupportive_careNot Availableunknown_status
NCT02060045
Prevention Ventilator Associated PneumoniaNo drug interventionspreventionNot Availablecompleted
NCT05877105
Effect of Selected Evidence-based Practices and Related Nurses' Education on the Incidence and Severity of Ventilator-associated PneumoniaNo drug interventionspreventionNot Availablecompleted
NCT02127528
Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive CareNo drug interventionsNot AvailableNot Availableunknown_status
NCT02634411
Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)No drug interventionstreatmentNot Availablecompleted
NCT00589693
To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumoniatreatment3terminated
NCT00935285
Ventilator-Associated Pneumonia (VAP) in Intensive Care Unit (ICU)No drug interventionsNot AvailableNot Availableunknown_status
NCT04882085
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adultstreatment4completed
NCT02116699
Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360)No drug interventionspreventionNot Availablecompleted
NCT02134106
Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteriatreatment2 / 3withdrawn
NCT04242706
VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUsNo drug interventionsprevention4completed
NCT01583413
CDC Prevention Epicenters Wake Up and Breathe CollaborativeNo drug interventionstreatmentNot Availablecompleted
NCT02615041
The Pharmacodynamics of Meropenem in Patient With Ventilator-associated PneumoniaNot Available4completed
NCT02515617
Medico-economic Study of the Subglottic Secretions Drainage in Prevention of Ventilator-associated Pneumonia (DEMETER)No drug interventionspreventionNot Availablecompleted
NCT06168734
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABPtreatment3not_yet_recruiting
NCT00610324
Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patientsprevention4completed
NCT01489124
The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated PneumoniaNot Available4completed
NCT00893763
Strategies To Prevent Pneumonia 2 (SToPP2)No drug interventionsprevention2completed
NCT02906722
Nebulized and Intravenous Colistin in Ventilator Associated-pneumoniatreatment3terminated
NCT02515448
A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumoniatreatment1completed
NCT01467648
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated PneumoniaNot Available4completed
NCT02070757
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)treatment3completed
NCT01546974
Ventilator-associated Pneumonia (VAP) and Humidification SystemNo drug interventionsprevention4unknown_status
NCT02077920
Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)prevention2completed
NCT03018431
CT Scan and Lung Ultrasonography to Improve Diagnostic of Ventilation Acquired Pneumonia in ICUNo drug interventionsNot AvailableNot Availableunknown_status
NCT02585180
Subglottic Secretions Surveillance to Predict Bacterial Pathogens Involved in Ventilator-associated PneumoniaNo drug interventionspreventionNot Availablecompleted
NCT02966392
Continuous Endotracheal Cuff Pressure Control to Prevent Ventilator Associated Respiratory InfectionsNo drug interventionspreventionNot Availablecompleted
NCT00502801
An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumoniatreatment2completed
NCT02019095
Clinical and Biological Markers in Acute Respiratory FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT02284438
Biofilm Formation on Different Endotracheal Tube MaterialsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01294943
Evaluating the Effectiveness of the Tongue Cleaner in Critical PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06076603
Comparison of Epithelial Lining Fluid and Blood Pharmacokinetics and Pharmacodynamics of Intravenous and Intravenous Plus Nebulized Polymyxin B in Multidrug Resistant Bacteria Ventilator-associated Pneumonia PatientsNot AvailableNot Availablerecruiting
NCT04700202
Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care UnitNo drug interventionsNot AvailableNot Availablecompleted
NCT03101202
To Compare Endotracheal Tube (ET) With Subglottic Suction Drainage and Standard ET in the Incidence of VAPNo drug interventionspreventionNot Availablecompleted
NCT05485051
Daily Chlorexidine Bath for Health Care Associated Infection PreventionNo drug interventionsprevention3completed
NCT05124977
Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive CareNo drug interventionshealth_services_researchNot Availablerecruiting
NCT03921645
Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB PneumoniaNo drug interventionssupportive_careNot Availableunknown_status
NCT04061083
Effects of Endotracheal Tube Cuff Pressure Control on Microaspiration of Gastric ContentsNo drug interventionspreventionNot Availablecompleted
NCT05671328
Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated PneumoniaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03267693
Gastrointestinal Complications in Association With Oropharyngeal and Respiratory Infections in Mechanical VentilationNo drug interventionsNot AvailableNot Availableunknown_status
NCT05696093
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unittreatment3recruiting
NCT00702871
A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumoniatreatment4completed
NCT05767671
Macrophage Programing in Acute Lung Injury: MiniBALNo drug interventionsbasic_scienceNot Availablerecruiting
NCT04739878
SUBSUS (SUBglottic Secretion at Ultrasound Score)No drug interventionsdiagnosticNot Availablecompleted
NCT05354778
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP StudytreatmentNot Availablerecruiting
NCT00484588
A Multi-Center Observational Surveillance Study of VAP Causing BacteriaNo drug interventionsNot AvailableNot Availablecompleted
NCT00588588
Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP)No drug interventionstreatment3withdrawn
NCT01935388
Common Canister Protocol for Inhaler Administration in Mechanically Ventilated PatientsNo drug interventionstreatment4completed
NCT03041207
Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT04344509
Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01069185
Differences in Morbidity Between a Necessity Endotracheal Suctioning Protocol Versus a Routine Endotracheal SuctioningNo drug interventionstreatmentNot Availablecompleted
NCT03303937
Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00518752
Effects of Oral Care in the Neuroscience ICUNo drug interventionstreatmentNot Availablecompleted
NCT03074552
Probiotic Prophylaxis for Microbiome Modulation and VAP or Infections Prevention in Multitrauma PatientsNo drug interventionspreventionNot Availablecompleted
NCT05517759
Application of VAP Bundle Among ICU NursesNo drug interventionsNot AvailableNot Availablecompleted
NCT02928042
Inhibition Effects of Probiotics on Pathogens Associated With VAPNo drug interventionsNot AvailableNot Availablecompleted
NCT04097899
Antimicrobial Stewardship Program and Ventilator Associated PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT06207513
Single-used Versus MultiPlE-used Endotracheal suCtIon cAtheters in Mechanically ventiLated ICU PatientsNo drug interventionspreventionNot Availablerecruiting
NCT03506113
GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) TrialNo drug interventionstreatment4completed
NCT05060718
HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia StrategiesNo drug interventionsNot AvailableNot Availablecompleted
NCT06090019
Ventilator Associated Pneumonia Care Bundle Prevention on Internship Students' Knowledge and Clinical PerformanceNo drug interventionspreventionNot Availablecompleted
NCT00771719
Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumoniatreatment1terminated
NCT00934934
Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatmentother2terminated
NCT05591924
Early Severe Illness TrAnslational BioLogy InformaticS in HumansNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04111224
Evaluation of pentraxin3 as a Marker for Ventilator Associated PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT05545735
The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 DaysNo drug interventionstreatment4recruiting
NCT00851435
Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosatreatment1 / 2completed
NCT06511986
M-I/E for Preventing VAP in Post-neurosurgical PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02632539
Air-impingement Manipulation to Clear Subglottic Secretion to Prevent VAP in Prolonged Intubated PatientsNo drug interventionsprevention3unknown_status
NCT04057625
Transthoracic Ultrasound in the Diagnosis and Follow-up of Ventilator Associated PneumoniaNo drug interventionsdiagnosticNot Availableunknown_status
NCT05205525
Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)No drug interventionsNot AvailableNot Availablecompleted
NCT06201130
Airway Microbiome Changes After Artificial Airway Exchange in Critically-ill Pediatric Patients.No drug interventionsNot AvailableNot Availablerecruiting
NCT00702130
Pravastatin and Ventilatory Associated Pneumoniaprevention0completed
NCT03382548
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung InfectionNo drug interventionstreatment3completed
NCT01379157
Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumoniatreatment4completed
NCT04149665
Semirecumbent Position by Mechanical VentilationNo drug interventionsNot AvailableNot Availableunknown_status
NCT01126320
Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard SystemNo drug interventionspreventionNot Availablecompleted
NCT01393431
Futility of Exhaled Breath Condensate pH Measurements in Ventilated Patients in Intensive Care Unit (ICU)No drug interventionsNot AvailableNot Availableterminated
NCT05549427
Ventilator Associated Pneumonia by Multi-Drug Resistant OrganismNo drug interventionsNot AvailableNot Availablecompleted
NCT00950027
Study of Povidone Iodine to Reduce Pulmonary Infection in Head Trauma and Cerebral Hemorrhage in Intensive Care Unitprevention3terminated
NCT04484727
"Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs"No drug interventionsNot AvailableNot Availablerecruiting
NCT04372576
Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04527276
Reducing the Incidence of VAP in Critically Ill Children and Assessment of Oral Care With CHXNo drug interventionspreventionNot Availablecompleted
NCT06243094
Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA)No drug interventionsNot AvailableNot Availablerecruiting
NCT03266380
Risk Factors and Common Preventive Measures for Ventilator Associated Pneumonia in Patients With Severe Traumatic Brain InjuryNo drug interventionsNot AvailableNot Availableunknown_status
NCT05972980
Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06134492
Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BALtreatment3recruiting
NCT04467892
Low Versus High Corticosteroid Use in Ventilator Associated Pneumoniatreatment2completed
NCT04911244
Diagnostic Modalities for VAP DetectionNo drug interventionsdiagnosticNot Availablecompleted
NCT01138540
The Gravity-VAP (Ventilator-Associated Pneumonia) TrialNo drug interventionsprevention3terminated
NCT06059040
Effect of Eliminating Gastric Residual Volume Monitoring on Ventilator Associated EventsNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT04987840
A Multi-Center Diagnostic Stewardship Program to Improve Respiratory Culture Utilization in Critically Ill ChildrenNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04840940
Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05076240
FilmArray® and Management of Ventilator Associated Pneumonia in COVID-19 ARDSNo drug interventionsNot AvailableNot Availablecompleted
NCT03982667
Research Title: Efficacy and Safety of Point- Of-care Procalcitonin Test to Reduce Antibiotic Exposure in VAPNo drug interventionsdiagnosticNot Availablecompleted
NCT00726167
Serum Procalcitonin Study in the Management of Ventilated PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05089968
Ventilation Associated Pneumonia and Covid-19No drug interventionsNot AvailableNot Availablecompleted
NCT04233268
RASCALS: Rapid Assay for Sick Children With Acute Lung Infection StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05989269
Diagnostic Stewardship for Ventilator Associated PneumoniaNo drug interventionsotherNot Availablerecruiting
NCT06181669
Pneumonia Direct PilotNo drug interventionsNot AvailableNot Availablerecruiting
NCT02203110
The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT03763695
Effectiveness of a VAP Prevention Bundle in the PICUNo drug interventionsNot AvailableNot Availableunknown_status
NCT04352855
Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study.Not AvailableNot Availableunknown_status
NCT03622450
The Effect of Colistin Inhalation on Ventilator Associated Pneumoniatreatment2 / 3completed
NCT02363023
Study of Different Etiologic Diagnostic Methods in Ventilator Associated Pneumonia (VAP)No drug interventionsNot AvailableNot Availableterminated
NCT04977843
Effect of E-BAL on Severity of VAP Assessed Through CPIS on the Patients of Traumatic Brain Injury in Neurocritical Care, Also Effect on Days of Ventilation and ICU Stay.No drug interventionspreventionNot Availableunknown_status
NCT02288390
Oral Care as a Preventive Measure of VAP; Miswak Versus Chlorhexidine and Toothbrush.No drug interventionspreventionNot Availablecompleted
NCT00498121
The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)No drug interventionsNot AvailableNot Availableterminated
NCT05206721
Open Suction Circuit Flushing With Chlorhexidine Decreases Ventilator-Associated Pneumonia: A Quasi-experimental StudyNo drug interventionsprevention0completed
NCT05624684
Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.No drug interventionsNot AvailableNot Availablecompleted
NCT00691587
Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosaprevention1 / 2completed
NCT06092554
Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)No drug interventionspreventionNot Availablerecruiting
NCT03937947
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05979545
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID DiagnosticsNo drug interventionstreatment4recruiting
NCT00234598
Strategies to Prevent Pneumonia (SToP Pneumonia)No drug interventionsprevention2completed
NCT04766983
Incidence of VAP in Patients With Severe COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT06000761
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care UnitNo drug interventionspreventionNot Availablerecruiting
NCT02096328
Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumoniatreatment2completed
NCT00396578
Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilationtreatment2completed
NCT00597688
Role of Oral Chlorhexidine Gel in Prevention of Ventilator Associated Pneumoniaprevention3completed
NCT03917888
Clinical Impact of Lung Ultrasound Monitoring for Diagnosis of VAPNo drug interventionsdiagnosticNot Availablecompleted
NCT01083407
Oral Care Interventions and Ventilator Associated Pneumonia in Critically Ill Childrenprevention1completed
NCT05913856
The Effectiveness of Oral Care With Chlorhexidine in Medical Intensive Care UnitNo drug interventionspreventionNot Availablerecruiting
NCT05331885
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2treatment3recruiting
NCT03871985
Efficacy of Two Intermittent Subglottic SecretionNo drug interventionspreventionNot Availableunknown_status
NCT05685615
PK of BV100 in Patients VABP Suspected or Confirmed to be Due to CRABtreatment2recruiting
NCT00861315
Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilationtreatment2 / 3unknown_status
NCT03294837
Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care UnitNo drug interventionsNot AvailableNot Availableunknown_status
NCT01798537
Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infectionsprevention2 / 3unknown_status
NCT04397952
Endotracheal Tube Cuff Pressure MeasurementNo drug interventionsNot AvailableNot Availablecompleted
NCT05719259
Perpetual Observational Study - Ventilator Associated PneumoniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04402359
Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDSNot AvailableNot Availablecompleted
NCT03631342
Comparison Between Different Ventilator Hyperinflation ManeuversNo drug interventionsotherNot Availablecompleted
NCT00829842
Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart SurgeryNo drug interventionsprevention3completed
NCT01477099
Toothbrushing and Ventilator-associated PneumoniaNo drug interventionsprevention4completed
NCT02078999
Biomarkers in Patients Undergoing Mechanical VentilationNo drug interventionsNot AvailableNot Availablecompleted
NCT05410106
Ventilator Aspiration With PneuX (PneuX vs Standard Care Feasibility RCT)No drug interventionspreventionNot Availablerecruiting
NCT02032849
Air-impingement Manipulation to Clear Subglottic Secretion Compared With Drainage Tube in Prolonged Intubated PatientsNo drug interventionspreventionNot Availableunknown_status
NCT02389036
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patientsprevention3completed
NCT05761613
Ceragenin Coated Endotracheal Tubes for the Prevention of Ventilator Associated PneumoniaNo drug interventionspreventionNot Availableactive_not_recruiting
NCT05167318
Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care UnitNo drug interventionspreventionNot Availableactive_not_recruiting
NCT05351619
Implementing Oral Care Bundle on Critical Care Nurses' Practice and Mechanically Ventilated Patients' OutcomesNo drug interventionspreventionNot Availableunknown_status
NCT01657396
Implementation and Evaluation of Revised Protocols for Oral Hygiene for Mechanically Ventilated PatientsNo drug interventionspreventionNot Availablecompleted
NCT06298435
Optimising Ventilatory Strategies by Using Positive Respiratory Integer MeasurementsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01948635
Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care UnitsNo drug interventionstreatmentNot Availablecompleted
NCT00495963
Diagnosis of Ventilator- Associated Pneumonia in Children: A Comparative Study of Bronchoscopic and Non-Bronchoscopic MethodsNo drug interventionsdiagnostic3completed
NCT04903886
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum EnterobacteriaceaeNo drug interventionsNot AvailableNot Availableunknown_status
NCT06113939
Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion SuctioningNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00950222
Impact of Imipenem With Amikacin Pharmacokinetic and PharmacodynamictreatmentNot Availablecompleted
NCT01188122
Optimal Endotracheal Cuff Pressure During Hospitalization in Intensive Care Units Using AnapnoGuard 100 SystemNo drug interventionssupportive_careNot Availablecompleted
NCT05486130
PREdiction of CEphalosporinase Producing Enterobacteria During Ventilator-associated Pneumonia for Therapeutic StewardshipNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04739748
Prognostic Biomarkers in Predicting Mortality in Respiratory Patients With Ventilator-Associated PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT03749226
Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumoniaprevention2 / 3terminated
NCT00297674
Intravenous Clarithromycin in Septic Syndrometreatment4completed
NCT03496220
Effect of Angulus on Patient-elevation ComplianceNo drug interventionspreventionNot Availablecompleted
NCT05258682
Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Diseasetreatment1 / 2unknown_status
NCT05895773
Oro-nasal Decontamination to Prevent Ventilator-associated Pneumoniaprevention2 / 3completed
NCT06554327
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective RegimensNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01501227
Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU PatientsNo drug interventionstreatment4unknown_status
NCT04348227
How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?No drug interventionsNot AvailableNot Availableunknown_status
NCT00434460
Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT06488794
Inhaled Colistin to Prevent Pediatric Ventilator-associated Pneumoniaprevention2 / 3not_yet_recruiting
NCT06066489
Effect of Educational Program About Preventive Care Bundle for Prevention of Ventilator Associated Pneumonia Among NewbornsNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT03477292
7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated PneumoniaNo drug interventionstreatmentNot Availablerecruiting
NCT03329092
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.No drug interventionstreatment3completed
NCT02120001
Efficacy Study on Silver-coated ETT Cleaned With a Novel DeviceNo drug interventionspreventionNot Availablecompleted
NCT04563104
Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT03418272
Cultures in PICU Patients Compared to Healthy ChildrenNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01382446
Chlorhexidine Gluconate Oral Care for Adults Experiencing TraumatreatmentNot Availablecompleted
NCT04488510
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00613795
Lactobacillus GG in the Prophylaxis of Ventilator Associated PneumoniaNo drug interventionsprevention3completed
NCT01975350
Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated PneumoniaNo drug interventionsNot AvailableNot Availableterminated
NCT00975923
Safe Critical Care: Testing Improvement StrategiesNo drug interventionshealth_services_researchNot Availablecompleted
NCT03442023
Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%treatment3unknown_status
NCT01118403
Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patientsprevention4withdrawn
NCT02462590
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trialprevention4completed
NCT04505202
Effect of Chlorhexidine-Induced Oral Care on Ventilator-Related Some Respiratory System ComplicationspreventionNot Availablecompleted
NCT05176353
Ventilator-associated Pneumonia (VAP) Diagnostic Stewardship TrialNo drug interventionshealth_services_researchNot Availablecompleted
NCT05738928
Microbiological Profile of VAP Patients in Respiratory ICUNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05952648
HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR ArrayNo drug interventionsdiagnosticNot Availablerecruiting
NCT06045429
Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisationprevention4recruiting
NCT04038814
The Effectiveness of the Modified Bundle in the Prevention of VAP.No drug interventionsNot AvailableNot Availablecompleted
NCT05575050
Impact of Teeth Brushing in Ventilated COVID-19 Patients.No drug interventionspreventionNot Availablecompleted
NCT04955821
Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGSNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06073834
LUNG INFECTION IN ICU (LUNG-I3)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06035796
Performance Study of Targeted Sequencing Technology for VAPNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05230472
Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumoniaprevention4completed
NCT06410664
Efficiency and Safety of the Prolonged Use of Heat and Moisture Exchangers in ICUNo drug interventionspreventionNot Availablerecruiting